28 related articles for article (PubMed ID: 33276979)
1. Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent.
Wu P; Zheng J; Huang T; Li D; Hu Q; Cheng A; Jiang Z; Jiao L; Zhao S; Zhang K
PLoS One; 2015; 10(9):e0138767. PubMed ID: 26406581
[TBL] [Abstract][Full Text] [Related]
2.
Avcı D; Özge Ö; Sönmez F; Tamer Ö; Başoğlu A; Atalay Y; Kurt BZ
Future Med Chem; 2024; 16(11):1109-1125. PubMed ID: 38916564
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
Bitew M; Desalegn T; Demissie TB; Belayneh A; Endale M; Eswaramoorthy R
PLoS One; 2021; 16(12):e0260853. PubMed ID: 34890431
[TBL] [Abstract][Full Text] [Related]
4. Developing a new multi-featured chitosan-quinoline Schiff base with potent antibacterial, antioxidant, and antidiabetic activities: design and molecular modeling simulation.
Abdel-Baky YM; Omer AM; El-Fakharany EM; Ammar YA; Abusaif MS; Ragab A
Sci Rep; 2023 Dec; 13(1):22792. PubMed ID: 38123716
[TBL] [Abstract][Full Text] [Related]
5. DFT calculations, molecular docking,
G S; K D; P S; N B
J Biomol Struct Dyn; 2023; 41(22):12997-13014. PubMed ID: 36752337
[TBL] [Abstract][Full Text] [Related]
6. Exploration of newly synthesized amantadine-thiourea conjugates for their DNA binding, anti-elastase, and anti-glioma potentials.
Arshad N; Shakeel M; Javed A; Perveen F; Saeed A; Ahmed A; Ismail H; Channar PA; Naseer F
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130231. PubMed ID: 38368975
[TBL] [Abstract][Full Text] [Related]
7. Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects.
Ornelas C; Astruc D
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631259
[TBL] [Abstract][Full Text] [Related]
8. New ferrocene integrated amphiphilic guanidines: Synthesis, spectroscopic elucidation, DFT calculation and in vitro α-amylase and α-glucosidase inhibition combined with molecular docking approach.
Zubair S; Badshah A; Patujo J; Khan M; Raheel A; Asghar F; Imtiaz S
Heliyon; 2023 Apr; 9(4):e14919. PubMed ID: 37064477
[TBL] [Abstract][Full Text] [Related]
9. Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations.
Taj MB; Raheel A; Ayub R; Alnajeebi AM; Abualnaja M; Habib AH; Alelwani W; Noor S; Ullah S; Al-Sehemi AG; Simsek R; Babteen NA; Alshater H
PLoS One; 2023; 18(2):e0262790. PubMed ID: 36730213
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in chemistry, structure, and various applications of 1-acyl-3-substituted thioureas: a detailed review.
Zahra U; Saeed A; Abdul Fattah T; Flörke U; Erben MF
RSC Adv; 2022 Apr; 12(20):12710-12745. PubMed ID: 35496330
[TBL] [Abstract][Full Text] [Related]
11. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
[TBL] [Abstract][Full Text] [Related]
12. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
Dhameja M; Gupta P
Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
[TBL] [Abstract][Full Text] [Related]
13. α-Glucosidase activity of oleanolic acid and its oxidative metabolites: DFT and Docking studies.
Anouar el H; Zakaria NS; Alsalme A; Shah SA
Mini Rev Med Chem; 2015; 15(14):1148-58. PubMed ID: 26205959
[TBL] [Abstract][Full Text] [Related]
14. Assessing the biological potential of new symmetrical ferrocene based bisthiourea analogues.
Patujo J; Azeem M; Khan M; Muhammad H; Raheel A; Fatima S; Mirza B; Hussain Z; Badshah A
Bioorg Chem; 2021 Jan; 106():104180. PubMed ID: 33276979
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
